Rishiroop (526492) 주식 개요Rishiroop Limited는 인도 및 국제적으로 폴리머, 폴리머 화합물 및 관련 제품의 제조 및 판매에 종사합니다. 자세히 보기526492 펀더멘털 분석스노우플레이크 점수가치 평가2/6미래 성장0/6과거 실적1/6재무 건전성5/6배당4/6강점주가수익률(9x)이 Indian 시장(24.2x)보다 낮습니다.위험 분석지난 5년간 매년 수익이 13.8% 감소했습니다.의미 있는 시가총액이 없습니다(₹893M)1.54% 의 배당금은 잉여현금흐름으로 잘 충당되지 않습니다.이익 마진 (14.3%)이 지난해 (24.2%)보다 낮습니다.모든 위험 점검 보기526492 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹97.4568.6% 고평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture0929m2016201920222025202620282031Revenue ₹746.2mEarnings ₹106.8mAdvancedSet Fair ValueView all narrativesFeatured narrative•Materials opportunityUpside Gold2 months ago author updated this narrativeSTFair Value from stuart_robertsCA$5.0768.4% 저평가 내재 할인율An Undervalued 3.3Moz Gold Project in CanadaKey takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.Read full narrative14.5kusers have viewed this narrative40users have liked this narrative1users have commented on this narrative283users have followed this narrativeRead narrativeRishiroop Limited 경쟁사Deep PolymersSymbol: BSE:541778Market cap: ₹967.2mPolychemSymbol: BSE:506605Market cap: ₹837.8mG M PolyplastSymbol: BSE:543239Market cap: ₹945.5mContinental PetroleumsSymbol: BSE:523232Market cap: ₹876.5m가격 이력 및 성과Rishiroop 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가₹97.4552주 최고가₹141.0052주 최저가₹71.50베타0.561개월 변동11.37%3개월 변동5.43%1년 변동-14.56%3년 변동-6.94%5년 변동-1.52%IPO 이후 변동4,653.66%최근 뉴스 및 업데이트공지 • May 02Rishiroop Limited to Report Q4, 2026 Results on May 16, 2026Rishiroop Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 16, 2026Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹87.50, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 7.1% over the past three years.Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹3.74 (vs ₹2.73 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹3.74 (up from ₹2.73 loss in 3Q 2025). Revenue: ₹193.1m (up 13% from 3Q 2025). Net income: ₹34.3m (up ₹59.3m from 3Q 2025). Profit margin: 18% (up from net loss in 3Q 2025). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.공지 • Jan 28Rishiroop Limited to Report Q3, 2026 Results on Feb 10, 2026Rishiroop Limited announced that they will report Q3, 2026 results on Feb 10, 2026New Risk • Jan 14New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹900.3m (US$9.96m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 6.4% per year over the past 5 years. Market cap is less than US$10m (₹900.3m market cap, or US$9.96m). Minor Risks Dividend is not well covered by cash flows (323% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.6% net profit margin).New Risk • Nov 15New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 61% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.4% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (323% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (₹977.8m market cap, or US$11.0m).더 많은 업데이트 보기Recent updates공지 • May 02Rishiroop Limited to Report Q4, 2026 Results on May 16, 2026Rishiroop Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 16, 2026Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹87.50, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 7.1% over the past three years.Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹3.74 (vs ₹2.73 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹3.74 (up from ₹2.73 loss in 3Q 2025). Revenue: ₹193.1m (up 13% from 3Q 2025). Net income: ₹34.3m (up ₹59.3m from 3Q 2025). Profit margin: 18% (up from net loss in 3Q 2025). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.공지 • Jan 28Rishiroop Limited to Report Q3, 2026 Results on Feb 10, 2026Rishiroop Limited announced that they will report Q3, 2026 results on Feb 10, 2026New Risk • Jan 14New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹900.3m (US$9.96m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 6.4% per year over the past 5 years. Market cap is less than US$10m (₹900.3m market cap, or US$9.96m). Minor Risks Dividend is not well covered by cash flows (323% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.6% net profit margin).New Risk • Nov 15New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 61% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.4% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (323% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (₹977.8m market cap, or US$11.0m).Reported Earnings • Nov 09Second quarter 2026 earnings released: EPS: ₹0.24 (vs ₹8.06 in 2Q 2025)Second quarter 2026 results: EPS: ₹0.24 (down from ₹8.06 in 2Q 2025). Revenue: ₹169.7m (down 19% from 2Q 2025). Net income: ₹2.19m (down 97% from 2Q 2025). Profit margin: 1.3% (down from 35% in 2Q 2025). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year.공지 • Oct 29Rishiroop Limited to Report Q2, 2026 Results on Nov 08, 2025Rishiroop Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 08, 2025Board Change • Sep 15Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Sitendu Sharma was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Aug 25Upcoming dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 01 September 2025. Payment date: 08 October 2025. Payout ratio is a comfortable 13% but the company is paying out more than the cash it is generating. Trailing yield: 1.2%. Lower than top quartile of Indian dividend payers (1.3%). Higher than average of industry peers (0.7%).Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹9.46 (vs ₹8.92 in 1Q 2025)First quarter 2026 results: EPS: ₹9.46 (up from ₹8.92 in 1Q 2025). Revenue: ₹266.7m (up 51% from 1Q 2025). Net income: ₹86.7m (up 6.1% from 1Q 2025). Profit margin: 33% (down from 46% in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.공지 • Aug 11Rishiroop Limited, Annual General Meeting, Sep 08, 2025Rishiroop Limited, Annual General Meeting, Sep 08, 2025, at 11:00 Indian Standard Time.공지 • Jul 25Rishiroop Limited to Report Q1, 2026 Results on Aug 11, 2025Rishiroop Limited announced that they will report Q1, 2026 results on Aug 11, 2025New Risk • May 23New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 107% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (118% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (14% net profit margin). Market cap is less than US$100m (₹1.08b market cap, or US$12.6m).Reported Earnings • May 16Full year 2025 earnings released: EPS: ₹11.64 (vs ₹26.36 in FY 2024)Full year 2025 results: EPS: ₹11.64 (down from ₹26.36 in FY 2024). Revenue: ₹840.8m (up 9.7% from FY 2024). Net income: ₹106.6m (down 56% from FY 2024). Profit margin: 13% (down from 32% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.공지 • May 05Rishiroop Limited to Report Q4, 2025 Results on May 15, 2025Rishiroop Limited announced that they will report Q4, 2025 results on May 15, 2025Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to ₹135, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 6.9% over the past three years.Buy Or Sell Opportunity • Feb 11Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 39% to ₹150. The fair value is estimated to be ₹192, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.4% over the last 3 years. Earnings per share has grown by 13%.공지 • Jan 28Rishiroop Limited to Report Q3, 2025 Results on Feb 10, 2025Rishiroop Limited announced that they will report Q3, 2025 results on Feb 10, 2025Reported Earnings • Nov 12Second quarter 2025 earnings released: EPS: ₹8.06 (vs ₹4.91 in 2Q 2024)Second quarter 2025 results: EPS: ₹8.06 (up from ₹4.91 in 2Q 2024). Revenue: ₹280.9m (up 43% from 2Q 2024). Net income: ₹73.8m (up 64% from 2Q 2024). Profit margin: 26% (up from 23% in 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings.공지 • Oct 25Rishiroop Limited to Report Q2, 2025 Results on Nov 11, 2024Rishiroop Limited announced that they will report Q2, 2025 results on Nov 11, 2024Valuation Update With 7 Day Price Move • Oct 14Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹227, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 90% over the past three years.Reported Earnings • Aug 13First quarter 2025 earnings released: EPS: ₹8.92 (vs ₹7.36 in 1Q 2024)First quarter 2025 results: EPS: ₹8.92 (up from ₹7.36 in 1Q 2024). Revenue: ₹272.9m (up 59% from 1Q 2024). Net income: ₹81.7m (up 21% from 1Q 2024). Profit margin: 30% (down from 39% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings.공지 • Aug 02Rishiroop Limited to Report Q1, 2025 Results on Aug 12, 2024Rishiroop Limited announced that they will report Q1, 2025 results on Aug 12, 2024Upcoming Dividend • Jul 29Upcoming dividend of ₹1.80 per shareEligible shareholders must have bought the stock before 05 August 2024. Payment date: 11 September 2024. Payout ratio is a comfortable 6.8% and this is well supported by cash flows. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.1%). Higher than average of industry peers (0.7%).공지 • Jul 16Rishiroop Limited, Annual General Meeting, Aug 12, 2024Rishiroop Limited, Annual General Meeting, Aug 12, 2024, at 11:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Jun 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹154, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 50% over the past three years.Buy Or Sell Opportunity • Jun 04Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to ₹154. The fair value is estimated to be ₹203, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.0% over the last 3 years. Earnings per share has declined by 34%.Reported Earnings • May 22Full year 2024 earnings released: EPS: ₹26.36 (vs ₹8.84 in FY 2023)Full year 2024 results: EPS: ₹26.36 (up from ₹8.84 in FY 2023). Revenue: ₹984.0m (up 11% from FY 2023). Net income: ₹241.6m (up 198% from FY 2023). Profit margin: 25% (up from 9.1% in FY 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has increased by 27% per year, which means it is well ahead of earnings.공지 • May 10Rishiroop Limited to Report Q4, 2024 Results on May 21, 2024Rishiroop Limited announced that they will report Q4, 2024 results on May 21, 2024Valuation Update With 7 Day Price Move • Feb 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹170, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 121% over the past three years.Reported Earnings • Feb 13Third quarter 2024 earnings released: EPS: ₹8.39 (vs ₹2.69 in 3Q 2023)Third quarter 2024 results: EPS: ₹8.39 (up from ₹2.69 in 3Q 2023). Revenue: ₹269.9m (up 37% from 3Q 2023). Net income: ₹76.8m (up 212% from 3Q 2023). Profit margin: 28% (up from 13% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.Reported Earnings • Nov 09Second quarter 2024 earnings released: EPS: ₹4.91 (vs ₹6.09 in 2Q 2023)Second quarter 2024 results: EPS: ₹4.91 (down from ₹6.09 in 2Q 2023). Revenue: ₹238.5m (up 1.5% from 2Q 2023). Net income: ₹45.0m (down 19% from 2Q 2023). Profit margin: 19% (down from 24% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings.공지 • Oct 28Rishiroop Limited to Report Q2, 2024 Results on Nov 08, 2023Rishiroop Limited announced that they will report Q2, 2024 results on Nov 08, 2023Upcoming Dividend • Aug 25Upcoming dividend of ₹1.50 per share at 1.1% yieldEligible shareholders must have bought the stock before 01 September 2023. Payment date: 08 October 2023. Payout ratio is a comfortable 17% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of Indian dividend payers (1.4%). Higher than average of industry peers (0.8%).Valuation Update With 7 Day Price Move • Aug 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹138, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 330% over the past three years.Reported Earnings • Aug 15First quarter 2024 earnings released: EPS: ₹7.36 (vs ₹1.29 loss in 1Q 2023)First quarter 2024 results: EPS: ₹7.36 (up from ₹1.29 loss in 1Q 2023). Revenue: ₹171.8m (down 32% from 1Q 2023). Net income: ₹67.5m (up ₹79.3m from 1Q 2023). Profit margin: 39% (up from net loss in 1Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 60% per year, which means it is tracking significantly ahead of earnings growth.공지 • Aug 11Rishiroop Limited, Annual General Meeting, Sep 08, 2023Rishiroop Limited, Annual General Meeting, Sep 08, 2023, at 11:00 Indian Standard Time. Agenda: To consider Adoption of Financial Statements and Reports of the Board of Directors and the Auditors thereon; to consider Declaration of Dividend; to consider Appointment of Director; and to discuss other matters if any.New Risk • Aug 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (8.2% net profit margin). Market cap is less than US$100m (₹1.02b market cap, or US$12.3m).공지 • Jul 29Rishiroop Limited to Report Q1, 2024 Results on Aug 10, 2023Rishiroop Limited announced that they will report Q1, 2024 results on Aug 10, 2023Reported Earnings • Feb 08Third quarter 2023 earnings released: EPS: ₹2.69 (vs ₹3.56 in 3Q 2022)Third quarter 2023 results: EPS: ₹2.69 (down from ₹3.56 in 3Q 2022). Revenue: ₹212.5m (down 9.7% from 3Q 2022). Net income: ₹24.6m (down 24% from 3Q 2022). Profit margin: 12% (down from 14% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth.공지 • Jan 24Rishiroop Limited to Report Q3, 2023 Results on Feb 07, 2023Rishiroop Limited announced that they will report Q3, 2023 results on Feb 07, 2023Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹6.09 (vs ₹6.39 in 2Q 2022)Second quarter 2023 results: EPS: ₹6.09 (down from ₹6.39 in 2Q 2022). Revenue: ₹279.4m (up 43% from 2Q 2022). Net income: ₹55.8m (down 10.0% from 2Q 2022). Profit margin: 20% (down from 32% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 47% per year, which means it is significantly lagging earnings growth.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Director Atul Shah was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공지 • Nov 03Rishiroop Limited to Report Q2, 2023 Results on Nov 12, 2022Rishiroop Limited announced that they will report Q2, 2023 results at 12:15 PM, Indian Standard Time on Nov 12, 2022Reported Earnings • Aug 11First quarter 2023 earnings released: ₹1.29 loss per share (vs ₹6.89 profit in 1Q 2022)First quarter 2023 results: ₹1.29 loss per share (down from ₹6.89 profit in 1Q 2022). Revenue: ₹253.1m (up 51% from 1Q 2022). Net loss: ₹11.8m (down 118% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth.공지 • Jul 28Rishiroop Limited to Report Q1, 2023 Results on Aug 09, 2022Rishiroop Limited announced that they will report Q1, 2023 results on Aug 09, 2022공지 • Jun 25Rishiroop Limited Declares Final Dividend for the Financial Year 2021-22Rishiroop Limited approved declaration of final dividend on equity shares for the financial year 2021-22 at 15% i. e. INR 1.50 per equity share at its AGM held on June 24, 2022.Upcoming Dividend • Jun 09Upcoming dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 16 June 2022. Payment date: 24 July 2022. Payout ratio is a comfortable 8.4% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of Indian dividend payers (1.8%). Higher than average of industry peers (0.8%).공지 • May 28Rishiroop Limited, Annual General Meeting, Jun 24, 2022Rishiroop Limited, Annual General Meeting, Jun 24, 2022, at 11:00 Indian Standard Time.공지 • May 21Rishiroop Limited Recommends Dividend for the Financial Year Ended March 31, 2022Rishiroop Limited at the board of directors meeting held on May 20,2022, recommended dividend at the rate of 15% INR 1.50 per equity share of INR 10 each (subject to deduction of tax at source) for the financial year ended March 31, 2022, for the approval of the shareholders at the upcoming 37th Annual General Meeting of the Company.Reported Earnings • May 21Full year 2022 earnings released: EPS: ₹17.78 (vs ₹30.92 in FY 2021)Full year 2022 results: EPS: ₹17.78 (down from ₹30.92 in FY 2021). Revenue: ₹935.1m (up 71% from FY 2021). Net income: ₹168.5m (down 44% from FY 2021). Profit margin: 18% (down from 55% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 11Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₹111, the stock trades at a trailing P/E ratio of 2.8x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 145% over the past three years.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Director Atul Shah was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹3.56 (down from ₹5.82 in 3Q 2021). Revenue: ₹248.8m (up 31% from 3Q 2021). Net income: ₹32.5m (down 43% from 3Q 2021). Profit margin: 13% (down from 30% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 45% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS ₹6.39 (vs ₹2.23 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹241.7m (up 93% from 2Q 2021). Net income: ₹62.0m (up 186% from 2Q 2021). Profit margin: 26% (up from 17% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 38% per year, which means it is significantly lagging earnings growth.공지 • Aug 28Rishiroop Limited (BSE:526492) announces an Equity Buyback for 640,000 shares, representing 6.6% for INR 80 million.Rishiroop Limited (BSE:526492) announces a share repurchase program. Under the program, the company will repurchase up to 640,000 shares, representing 6.6% of its issued share capital for INR 80 million. The shares will be repurchased at a price of INR 125 per share. The company has fixed September 9, 2021, as record date. As of August 20, 2021, the company had 9,701,288 shares in issue.Valuation Update With 7 Day Price Move • May 28Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to ₹87.55, the stock trades at a trailing P/E ratio of 2.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 22% over the past three years.Reported Earnings • May 23Full year 2021 earnings released: EPS ₹30.92 (vs ₹2.93 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹660.7m (up 63% from FY 2020). Net income: ₹300.0m (up ₹328.4m from FY 2020). Profit margin: 45% (up from net loss in FY 2020). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.공지 • May 22Rishiroop Limited Recommends Dividend for the Year Ended March 31, 2021Rishiroop Limited announced that at its board meeting held on May 21, 2021, the board of directors recommended dividend at 12% that is INR 1.20 per equity share of INR 10/- each (subject to deduction of tax at source) for the financial year ended March 31, 2021, for the approval of the shareholders at the upcoming 36th Annual General Meeting of the company. Dividend, if approved by the shareholders, will be paid/dispatched within the statutory period as prescribed under Companies Act, 2013.Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₹102, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 19x in the Chemicals industry in India. Negligible returns to shareholders over past three years.Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹92.25, the stock is trading at a trailing P/E ratio of 16.9x, up from the previous P/E ratio of 14.5x. This compares to an average P/E of 17x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 23%.Upcoming Dividend • Feb 10Upcoming Dividend of ₹5.00 Per ShareWill be paid on the 5th of March to those who are registered shareholders by the 17th of February. The trailing yield of 5.4% is in the top quartile of Indian dividend payers (1.9%), and it is higher than industry peers (0.7%).Reported Earnings • Feb 06Third quarter 2021 earnings released: EPS ₹5.82 (vs ₹1.12 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹231.2m (up 176% from 3Q 2020). Net income: ₹56.5m (up 421% from 3Q 2020). Profit margin: 24% (up from 13% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Feb 04New 90-day high: ₹72.00The company is up 83% from its price of ₹39.30 on 06 November 2020. The Indian market is up 23% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period.공지 • Jan 28Rishiroop Limited to Report Q3, 2021 Results on Feb 05, 2021Rishiroop Limited announced that they will report Q3, 2021 results on Feb 05, 2021Valuation Update With 7 Day Price Move • Nov 25Market bids up stock over the past weekAfter last week's 18% share price gain to ₹59.90, the stock is trading at a trailing P/E ratio of 77.6x, up from the previous P/E ratio of 65.8x. This compares to an average P/E of 16x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 53%.Valuation Update With 7 Day Price Move • Nov 17Market bids up stock over the past weekAfter last week's 16% share price gain to ₹52.30, the stock is trading at a trailing P/E ratio of 67.8x, up from the previous P/E ratio of 58.4x. This compares to an average P/E of 16x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 55%.Valuation Update With 7 Day Price Move • Nov 13Market bids up stock over the past weekAfter last week's 25% share price gain to ₹49.25, the stock is trading at a trailing P/E ratio of 63.8x, up from the previous P/E ratio of 50.9x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 58%.Valuation Update With 7 Day Price Move • Nov 09Market bids up stock over the past weekAfter last week's 17% share price gain to ₹46.70, the stock is trading at a trailing P/E ratio of 60.5x, up from the previous P/E ratio of 51.8x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 53%.Reported Earnings • Nov 01First half earnings releasedOver the last 12 months the company has reported total profits of ₹7.48m, down 84% from the prior year. Total revenue was ₹397.9m over the last 12 months, down 20% from the prior year.Is New 90 Day High Low • Oct 30New 90-day high: ₹37.15The company is up 45% from its price of ₹25.70 on 31 July 2020. The Indian market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period.Recent Insider Transactions • Oct 02Insider recently bought ₹66k worth of stockOn the 28th of September, Shradha Khanna bought around 2k shares on-market at roughly ₹32.77 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.공지 • Sep 13Rishiroop Limited to Report Q1, 2021 Results on Aug 24, 2020Rishiroop Limited announced that they will report Q1, 2021 results on Aug 24, 2020공지 • Jun 28Rishiroop Limited to Report Q4, 2020 Results on Jun 29, 2020Rishiroop Limited announced that they will report Q4, 2020 results on Jun 29, 2020주주 수익률526492IN ChemicalsIN 시장7D5.2%3.4%0.9%1Y-14.6%1.8%6.1%전체 주주 수익률 보기수익률 대 산업: 526492은 지난 1년 동안 1.8%의 수익을 기록한 Indian Chemicals 산업보다 저조한 성과를 냈습니다.수익률 대 시장: 526492은 지난 1년 동안 6.1%를 기록한 Indian 시장보다 저조한 성과를 냈습니다.주가 변동성Is 526492's price volatile compared to industry and market?526492 volatility526492 Average Weekly Movement6.9%Chemicals Industry Average Movement7.1%Market Average Movement7.2%10% most volatile stocks in IN Market10.2%10% least volatile stocks in IN Market4.7%안정적인 주가: 526492는 지난 3개월 동안 Indian 시장에 비해 주가 변동성이 크지 않았습니다.시간에 따른 변동성: 526492의 주간 변동성(7%)은 지난 1년 동안 안정적이었습니다.회사 소개설립직원 수CEO웹사이트198435Aditya Kapoorwww.rishiroop.in리시루프는 인도 및 국제적으로 폴리머, 폴리머 화합물 및 관련 제품의 제조 및 판매에 종사하고 있습니다. 이 회사는 염소 처리된 고무를 클로럽이라는 브랜드로, 아크릴로니트릴 부타디엔 고무와 폴리염화비닐 폴리머 블렌드를 비노프렌과 비노플라스트라는 브랜드로 제공합니다. 또한 아크릴로니트릴 부타디엔 고무, 에틸렌 프로필렌 디엔 고무, 폴리 부타디엔 고무, 폴리 클로로프렌 고무, 스티렌 부타디엔 고무 스티렌 블록 코폴리머, 열가소성 폴리올레핀도 제공합니다, 열가소성 가황제, 아크릴로니트릴 부타디엔 공중합체 라텍스, 폴리클로로프렌 라텍스, 스티렌 부타디엔 공중합체 라텍스, 카본 블랙, 기능성 필러, 누에버그 규토, 나프텐 오일, 고분자 가소제 등 다양한 제품을 제공합니다.더 보기Rishiroop Limited 기초 지표 요약Rishiroop의 순이익과 매출은 시가총액과 어떻게 비교됩니까?526492 기초 통계시가총액₹892.99m순이익 (TTM)₹99.28m매출 (TTM)₹693.81m9.0x주가수익비율(P/E)1.3x주가매출비율(P/S)526492는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표526492 손익계산서 (TTM)매출₹693.81m매출원가₹554.64m총이익₹139.17m기타 비용₹39.89m순이익₹99.28m최근 보고된 실적Dec 31, 2025다음 실적 발표일May 16, 2026주당순이익(EPS)10.83총이익률20.06%순이익률14.31%부채/자본 비율0.2%526492의 장기 실적은 어땠습니까?과거 실적 및 비교 보기배당1.5%현재 배당 수익률13%배당 성향View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/07 20:10종가2026/05/07 00:00수익2025/12/31연간 수익2025/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Rishiroop Limited는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Vijay MadunalaFirstCall Research
Featured narrative•Materials opportunityUpside Gold2 months ago author updated this narrativeSTFair Value from stuart_robertsCA$5.0768.4% 저평가 내재 할인율An Undervalued 3.3Moz Gold Project in CanadaKey takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.Read full narrative14.5kusers have viewed this narrative40users have liked this narrative1users have commented on this narrative283users have followed this narrativeRead narrative
공지 • May 02Rishiroop Limited to Report Q4, 2026 Results on May 16, 2026Rishiroop Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 16, 2026
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹87.50, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 7.1% over the past three years.
Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹3.74 (vs ₹2.73 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹3.74 (up from ₹2.73 loss in 3Q 2025). Revenue: ₹193.1m (up 13% from 3Q 2025). Net income: ₹34.3m (up ₹59.3m from 3Q 2025). Profit margin: 18% (up from net loss in 3Q 2025). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
공지 • Jan 28Rishiroop Limited to Report Q3, 2026 Results on Feb 10, 2026Rishiroop Limited announced that they will report Q3, 2026 results on Feb 10, 2026
New Risk • Jan 14New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹900.3m (US$9.96m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 6.4% per year over the past 5 years. Market cap is less than US$10m (₹900.3m market cap, or US$9.96m). Minor Risks Dividend is not well covered by cash flows (323% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.6% net profit margin).
New Risk • Nov 15New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 61% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.4% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (323% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (₹977.8m market cap, or US$11.0m).
공지 • May 02Rishiroop Limited to Report Q4, 2026 Results on May 16, 2026Rishiroop Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 16, 2026
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹87.50, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 7.1% over the past three years.
Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹3.74 (vs ₹2.73 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹3.74 (up from ₹2.73 loss in 3Q 2025). Revenue: ₹193.1m (up 13% from 3Q 2025). Net income: ₹34.3m (up ₹59.3m from 3Q 2025). Profit margin: 18% (up from net loss in 3Q 2025). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
공지 • Jan 28Rishiroop Limited to Report Q3, 2026 Results on Feb 10, 2026Rishiroop Limited announced that they will report Q3, 2026 results on Feb 10, 2026
New Risk • Jan 14New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹900.3m (US$9.96m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 6.4% per year over the past 5 years. Market cap is less than US$10m (₹900.3m market cap, or US$9.96m). Minor Risks Dividend is not well covered by cash flows (323% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.6% net profit margin).
New Risk • Nov 15New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 61% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.4% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (323% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (₹977.8m market cap, or US$11.0m).
Reported Earnings • Nov 09Second quarter 2026 earnings released: EPS: ₹0.24 (vs ₹8.06 in 2Q 2025)Second quarter 2026 results: EPS: ₹0.24 (down from ₹8.06 in 2Q 2025). Revenue: ₹169.7m (down 19% from 2Q 2025). Net income: ₹2.19m (down 97% from 2Q 2025). Profit margin: 1.3% (down from 35% in 2Q 2025). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year.
공지 • Oct 29Rishiroop Limited to Report Q2, 2026 Results on Nov 08, 2025Rishiroop Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 08, 2025
Board Change • Sep 15Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Sitendu Sharma was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Aug 25Upcoming dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 01 September 2025. Payment date: 08 October 2025. Payout ratio is a comfortable 13% but the company is paying out more than the cash it is generating. Trailing yield: 1.2%. Lower than top quartile of Indian dividend payers (1.3%). Higher than average of industry peers (0.7%).
Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹9.46 (vs ₹8.92 in 1Q 2025)First quarter 2026 results: EPS: ₹9.46 (up from ₹8.92 in 1Q 2025). Revenue: ₹266.7m (up 51% from 1Q 2025). Net income: ₹86.7m (up 6.1% from 1Q 2025). Profit margin: 33% (down from 46% in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
공지 • Aug 11Rishiroop Limited, Annual General Meeting, Sep 08, 2025Rishiroop Limited, Annual General Meeting, Sep 08, 2025, at 11:00 Indian Standard Time.
공지 • Jul 25Rishiroop Limited to Report Q1, 2026 Results on Aug 11, 2025Rishiroop Limited announced that they will report Q1, 2026 results on Aug 11, 2025
New Risk • May 23New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 107% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (118% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (14% net profit margin). Market cap is less than US$100m (₹1.08b market cap, or US$12.6m).
Reported Earnings • May 16Full year 2025 earnings released: EPS: ₹11.64 (vs ₹26.36 in FY 2024)Full year 2025 results: EPS: ₹11.64 (down from ₹26.36 in FY 2024). Revenue: ₹840.8m (up 9.7% from FY 2024). Net income: ₹106.6m (down 56% from FY 2024). Profit margin: 13% (down from 32% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
공지 • May 05Rishiroop Limited to Report Q4, 2025 Results on May 15, 2025Rishiroop Limited announced that they will report Q4, 2025 results on May 15, 2025
Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to ₹135, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 6.9% over the past three years.
Buy Or Sell Opportunity • Feb 11Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 39% to ₹150. The fair value is estimated to be ₹192, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.4% over the last 3 years. Earnings per share has grown by 13%.
공지 • Jan 28Rishiroop Limited to Report Q3, 2025 Results on Feb 10, 2025Rishiroop Limited announced that they will report Q3, 2025 results on Feb 10, 2025
Reported Earnings • Nov 12Second quarter 2025 earnings released: EPS: ₹8.06 (vs ₹4.91 in 2Q 2024)Second quarter 2025 results: EPS: ₹8.06 (up from ₹4.91 in 2Q 2024). Revenue: ₹280.9m (up 43% from 2Q 2024). Net income: ₹73.8m (up 64% from 2Q 2024). Profit margin: 26% (up from 23% in 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings.
공지 • Oct 25Rishiroop Limited to Report Q2, 2025 Results on Nov 11, 2024Rishiroop Limited announced that they will report Q2, 2025 results on Nov 11, 2024
Valuation Update With 7 Day Price Move • Oct 14Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹227, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 90% over the past three years.
Reported Earnings • Aug 13First quarter 2025 earnings released: EPS: ₹8.92 (vs ₹7.36 in 1Q 2024)First quarter 2025 results: EPS: ₹8.92 (up from ₹7.36 in 1Q 2024). Revenue: ₹272.9m (up 59% from 1Q 2024). Net income: ₹81.7m (up 21% from 1Q 2024). Profit margin: 30% (down from 39% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings.
공지 • Aug 02Rishiroop Limited to Report Q1, 2025 Results on Aug 12, 2024Rishiroop Limited announced that they will report Q1, 2025 results on Aug 12, 2024
Upcoming Dividend • Jul 29Upcoming dividend of ₹1.80 per shareEligible shareholders must have bought the stock before 05 August 2024. Payment date: 11 September 2024. Payout ratio is a comfortable 6.8% and this is well supported by cash flows. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.1%). Higher than average of industry peers (0.7%).
공지 • Jul 16Rishiroop Limited, Annual General Meeting, Aug 12, 2024Rishiroop Limited, Annual General Meeting, Aug 12, 2024, at 11:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Jun 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹154, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 50% over the past three years.
Buy Or Sell Opportunity • Jun 04Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to ₹154. The fair value is estimated to be ₹203, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.0% over the last 3 years. Earnings per share has declined by 34%.
Reported Earnings • May 22Full year 2024 earnings released: EPS: ₹26.36 (vs ₹8.84 in FY 2023)Full year 2024 results: EPS: ₹26.36 (up from ₹8.84 in FY 2023). Revenue: ₹984.0m (up 11% from FY 2023). Net income: ₹241.6m (up 198% from FY 2023). Profit margin: 25% (up from 9.1% in FY 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has increased by 27% per year, which means it is well ahead of earnings.
공지 • May 10Rishiroop Limited to Report Q4, 2024 Results on May 21, 2024Rishiroop Limited announced that they will report Q4, 2024 results on May 21, 2024
Valuation Update With 7 Day Price Move • Feb 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹170, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 121% over the past three years.
Reported Earnings • Feb 13Third quarter 2024 earnings released: EPS: ₹8.39 (vs ₹2.69 in 3Q 2023)Third quarter 2024 results: EPS: ₹8.39 (up from ₹2.69 in 3Q 2023). Revenue: ₹269.9m (up 37% from 3Q 2023). Net income: ₹76.8m (up 212% from 3Q 2023). Profit margin: 28% (up from 13% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.
Reported Earnings • Nov 09Second quarter 2024 earnings released: EPS: ₹4.91 (vs ₹6.09 in 2Q 2023)Second quarter 2024 results: EPS: ₹4.91 (down from ₹6.09 in 2Q 2023). Revenue: ₹238.5m (up 1.5% from 2Q 2023). Net income: ₹45.0m (down 19% from 2Q 2023). Profit margin: 19% (down from 24% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings.
공지 • Oct 28Rishiroop Limited to Report Q2, 2024 Results on Nov 08, 2023Rishiroop Limited announced that they will report Q2, 2024 results on Nov 08, 2023
Upcoming Dividend • Aug 25Upcoming dividend of ₹1.50 per share at 1.1% yieldEligible shareholders must have bought the stock before 01 September 2023. Payment date: 08 October 2023. Payout ratio is a comfortable 17% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of Indian dividend payers (1.4%). Higher than average of industry peers (0.8%).
Valuation Update With 7 Day Price Move • Aug 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹138, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 330% over the past three years.
Reported Earnings • Aug 15First quarter 2024 earnings released: EPS: ₹7.36 (vs ₹1.29 loss in 1Q 2023)First quarter 2024 results: EPS: ₹7.36 (up from ₹1.29 loss in 1Q 2023). Revenue: ₹171.8m (down 32% from 1Q 2023). Net income: ₹67.5m (up ₹79.3m from 1Q 2023). Profit margin: 39% (up from net loss in 1Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 60% per year, which means it is tracking significantly ahead of earnings growth.
공지 • Aug 11Rishiroop Limited, Annual General Meeting, Sep 08, 2023Rishiroop Limited, Annual General Meeting, Sep 08, 2023, at 11:00 Indian Standard Time. Agenda: To consider Adoption of Financial Statements and Reports of the Board of Directors and the Auditors thereon; to consider Declaration of Dividend; to consider Appointment of Director; and to discuss other matters if any.
New Risk • Aug 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (8.2% net profit margin). Market cap is less than US$100m (₹1.02b market cap, or US$12.3m).
공지 • Jul 29Rishiroop Limited to Report Q1, 2024 Results on Aug 10, 2023Rishiroop Limited announced that they will report Q1, 2024 results on Aug 10, 2023
Reported Earnings • Feb 08Third quarter 2023 earnings released: EPS: ₹2.69 (vs ₹3.56 in 3Q 2022)Third quarter 2023 results: EPS: ₹2.69 (down from ₹3.56 in 3Q 2022). Revenue: ₹212.5m (down 9.7% from 3Q 2022). Net income: ₹24.6m (down 24% from 3Q 2022). Profit margin: 12% (down from 14% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth.
공지 • Jan 24Rishiroop Limited to Report Q3, 2023 Results on Feb 07, 2023Rishiroop Limited announced that they will report Q3, 2023 results on Feb 07, 2023
Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹6.09 (vs ₹6.39 in 2Q 2022)Second quarter 2023 results: EPS: ₹6.09 (down from ₹6.39 in 2Q 2022). Revenue: ₹279.4m (up 43% from 2Q 2022). Net income: ₹55.8m (down 10.0% from 2Q 2022). Profit margin: 20% (down from 32% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 47% per year, which means it is significantly lagging earnings growth.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Director Atul Shah was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공지 • Nov 03Rishiroop Limited to Report Q2, 2023 Results on Nov 12, 2022Rishiroop Limited announced that they will report Q2, 2023 results at 12:15 PM, Indian Standard Time on Nov 12, 2022
Reported Earnings • Aug 11First quarter 2023 earnings released: ₹1.29 loss per share (vs ₹6.89 profit in 1Q 2022)First quarter 2023 results: ₹1.29 loss per share (down from ₹6.89 profit in 1Q 2022). Revenue: ₹253.1m (up 51% from 1Q 2022). Net loss: ₹11.8m (down 118% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth.
공지 • Jul 28Rishiroop Limited to Report Q1, 2023 Results on Aug 09, 2022Rishiroop Limited announced that they will report Q1, 2023 results on Aug 09, 2022
공지 • Jun 25Rishiroop Limited Declares Final Dividend for the Financial Year 2021-22Rishiroop Limited approved declaration of final dividend on equity shares for the financial year 2021-22 at 15% i. e. INR 1.50 per equity share at its AGM held on June 24, 2022.
Upcoming Dividend • Jun 09Upcoming dividend of ₹1.50 per shareEligible shareholders must have bought the stock before 16 June 2022. Payment date: 24 July 2022. Payout ratio is a comfortable 8.4% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of Indian dividend payers (1.8%). Higher than average of industry peers (0.8%).
공지 • May 28Rishiroop Limited, Annual General Meeting, Jun 24, 2022Rishiroop Limited, Annual General Meeting, Jun 24, 2022, at 11:00 Indian Standard Time.
공지 • May 21Rishiroop Limited Recommends Dividend for the Financial Year Ended March 31, 2022Rishiroop Limited at the board of directors meeting held on May 20,2022, recommended dividend at the rate of 15% INR 1.50 per equity share of INR 10 each (subject to deduction of tax at source) for the financial year ended March 31, 2022, for the approval of the shareholders at the upcoming 37th Annual General Meeting of the Company.
Reported Earnings • May 21Full year 2022 earnings released: EPS: ₹17.78 (vs ₹30.92 in FY 2021)Full year 2022 results: EPS: ₹17.78 (down from ₹30.92 in FY 2021). Revenue: ₹935.1m (up 71% from FY 2021). Net income: ₹168.5m (down 44% from FY 2021). Profit margin: 18% (down from 55% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 11Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₹111, the stock trades at a trailing P/E ratio of 2.8x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 145% over the past three years.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Director Atul Shah was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹3.56 (down from ₹5.82 in 3Q 2021). Revenue: ₹248.8m (up 31% from 3Q 2021). Net income: ₹32.5m (down 43% from 3Q 2021). Profit margin: 13% (down from 30% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 45% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS ₹6.39 (vs ₹2.23 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹241.7m (up 93% from 2Q 2021). Net income: ₹62.0m (up 186% from 2Q 2021). Profit margin: 26% (up from 17% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 38% per year, which means it is significantly lagging earnings growth.
공지 • Aug 28Rishiroop Limited (BSE:526492) announces an Equity Buyback for 640,000 shares, representing 6.6% for INR 80 million.Rishiroop Limited (BSE:526492) announces a share repurchase program. Under the program, the company will repurchase up to 640,000 shares, representing 6.6% of its issued share capital for INR 80 million. The shares will be repurchased at a price of INR 125 per share. The company has fixed September 9, 2021, as record date. As of August 20, 2021, the company had 9,701,288 shares in issue.
Valuation Update With 7 Day Price Move • May 28Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to ₹87.55, the stock trades at a trailing P/E ratio of 2.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 22% over the past three years.
Reported Earnings • May 23Full year 2021 earnings released: EPS ₹30.92 (vs ₹2.93 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹660.7m (up 63% from FY 2020). Net income: ₹300.0m (up ₹328.4m from FY 2020). Profit margin: 45% (up from net loss in FY 2020). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
공지 • May 22Rishiroop Limited Recommends Dividend for the Year Ended March 31, 2021Rishiroop Limited announced that at its board meeting held on May 21, 2021, the board of directors recommended dividend at 12% that is INR 1.20 per equity share of INR 10/- each (subject to deduction of tax at source) for the financial year ended March 31, 2021, for the approval of the shareholders at the upcoming 36th Annual General Meeting of the company. Dividend, if approved by the shareholders, will be paid/dispatched within the statutory period as prescribed under Companies Act, 2013.
Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₹102, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 19x in the Chemicals industry in India. Negligible returns to shareholders over past three years.
Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹92.25, the stock is trading at a trailing P/E ratio of 16.9x, up from the previous P/E ratio of 14.5x. This compares to an average P/E of 17x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 23%.
Upcoming Dividend • Feb 10Upcoming Dividend of ₹5.00 Per ShareWill be paid on the 5th of March to those who are registered shareholders by the 17th of February. The trailing yield of 5.4% is in the top quartile of Indian dividend payers (1.9%), and it is higher than industry peers (0.7%).
Reported Earnings • Feb 06Third quarter 2021 earnings released: EPS ₹5.82 (vs ₹1.12 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹231.2m (up 176% from 3Q 2020). Net income: ₹56.5m (up 421% from 3Q 2020). Profit margin: 24% (up from 13% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Feb 04New 90-day high: ₹72.00The company is up 83% from its price of ₹39.30 on 06 November 2020. The Indian market is up 23% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period.
공지 • Jan 28Rishiroop Limited to Report Q3, 2021 Results on Feb 05, 2021Rishiroop Limited announced that they will report Q3, 2021 results on Feb 05, 2021
Valuation Update With 7 Day Price Move • Nov 25Market bids up stock over the past weekAfter last week's 18% share price gain to ₹59.90, the stock is trading at a trailing P/E ratio of 77.6x, up from the previous P/E ratio of 65.8x. This compares to an average P/E of 16x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 53%.
Valuation Update With 7 Day Price Move • Nov 17Market bids up stock over the past weekAfter last week's 16% share price gain to ₹52.30, the stock is trading at a trailing P/E ratio of 67.8x, up from the previous P/E ratio of 58.4x. This compares to an average P/E of 16x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 55%.
Valuation Update With 7 Day Price Move • Nov 13Market bids up stock over the past weekAfter last week's 25% share price gain to ₹49.25, the stock is trading at a trailing P/E ratio of 63.8x, up from the previous P/E ratio of 50.9x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 58%.
Valuation Update With 7 Day Price Move • Nov 09Market bids up stock over the past weekAfter last week's 17% share price gain to ₹46.70, the stock is trading at a trailing P/E ratio of 60.5x, up from the previous P/E ratio of 51.8x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 53%.
Reported Earnings • Nov 01First half earnings releasedOver the last 12 months the company has reported total profits of ₹7.48m, down 84% from the prior year. Total revenue was ₹397.9m over the last 12 months, down 20% from the prior year.
Is New 90 Day High Low • Oct 30New 90-day high: ₹37.15The company is up 45% from its price of ₹25.70 on 31 July 2020. The Indian market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period.
Recent Insider Transactions • Oct 02Insider recently bought ₹66k worth of stockOn the 28th of September, Shradha Khanna bought around 2k shares on-market at roughly ₹32.77 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
공지 • Sep 13Rishiroop Limited to Report Q1, 2021 Results on Aug 24, 2020Rishiroop Limited announced that they will report Q1, 2021 results on Aug 24, 2020
공지 • Jun 28Rishiroop Limited to Report Q4, 2020 Results on Jun 29, 2020Rishiroop Limited announced that they will report Q4, 2020 results on Jun 29, 2020
